across nine states as retailers beef up the more lucrative aspects of the prescription drug business, the company said July 25, 2024. In this photo is Walmart Supercenter store #5260 in Springdale, Arkansas. Walmart is expanding its “autoimmune-focused” specialty pharmacy business to more than 30 locations across nine states as retailers beef up the more lucrative aspects of the prescription drug business.
The expansion brings the total number of autoimmune-focused specialty pharmacies to 31 across nine states from a half dozen in four states currently. Such pharmacies will be located in Alabama, Idaho, Louisiana, New York, Oregon, Pennsylvania, Rhode Island, Texas and Wisconsin after the expansion. Pharmacy, a $24 billion business that integrates a new pharmacy equipped to handle gene and cell therapies with its existing pharmacy assets including the large specialty pharmacy and home delivery business, AllianceRx.
“We have them in the stores – because when you think of the care for those conditions — we can also provide nutrition and over-the-counter products,” Aleata Postell, Walmart’s group director of specialty pharmacy, said in an interview. “We can bring everything together there.”